(Q57114735)

1

0 references

Karin M J van Nieuwkerk

3

0 references

Joost P H Drenth

4

0 references

Alexander C Poen

5

0 references

Ben J M Witteman

6

0 references

Hans A R E Tuynman

7

0 references

Ulrich Beuers

8

0 references

Cyriel Y Ponsioen

Inflammatory Bowel Diseases

9

0 references

language of work or name

English

0 references

publication date

December 2012

0 references

published in

0 references

volume

18

0 references

issue

12

0 references

page(s)

2270-6

0 references

cites work

Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population

1 reference

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis

21 January 2018

1 reference

Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis.

21 January 2018

1 reference

The geoepidemiology of primary biliary cirrhosis

21 January 2018

1 reference

Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study

21 January 2018

1 reference

Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease

21 January 2018

1 reference

Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis.

21 January 2018

1 reference

Ileal biopsy: Clinical indications, endoscopic and histopathologic findings in 10,000 patients.

21 January 2018

1 reference

Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study

21 January 2018

1 reference

Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis

21 January 2018

1 reference

Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease

21 January 2018

1 reference

Ulcerative colitis has an aggressive course after orthotopic liver transplantation for primary sclerosing cholangitis

21 January 2018

1 reference

Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?

21 January 2018

1 reference

Increased Risk of Primary Sclerosing Cholangitis and Ulcerative Colitis in First-Degree Relatives of Patients With Primary Sclerosing Cholangitis

21 January 2018

1 reference

Genome-wide association analysis in primary sclerosing cholangitis

21 January 2018

1 reference

Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci

21 January 2018

1 reference

Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9

21 January 2018

1 reference

Risk of colorectal neoplasia in patients with primary sclerosing cholangitis.

21 January 2018

1 reference

Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study

21 January 2018

1 reference

Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease

21 January 2018

1 reference

More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis.

21 January 2018

1 reference

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

21 January 2018

1 reference

The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis

21 January 2018

1 reference

High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia

21 January 2018

1 reference